Luís Almenar - Concepedia

Author

Luís Almenar

Hospital Universitari i Politècnic La Fe

Also Known As

L ALMENAR, L Almenar, L. ALMENAR, L. Almenar, LUIS ALMENAR, Luis Almenar, Luís Almenar, on behalf of the PRACMA investigators

249

Publications

4.3K

Citations

H-Index

106

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Hospital Universitario Puerta de Hierro Majadahonda Hospital Universitario Reina Sofía Complexo Hospitalario Universitario A Coruña Hospital Universitario Central de Asturias

About

Luís Almenar is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, cardiology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	57	1.9K
2	Public Health	9	9	335
3	Health Sciences	3	3	127
4	Natural Sciences	1	1	40
5	Nursing	1	1	20

Luís Almenar

Publications

Citations

H-Index

Page 1

	Year	Citations
Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial Michael Grimm, Mauro Rinaldi, Nizar Yonan, American Journal of Transplantation Transplant RejectionHeart FailureTransplantationFirst BparImmunosuppressive Therapy	2006	194
Efficacy and Safety of Intermittent Intravenous Outpatient Administration of Levosimendan in Patients With Advanced Heart Failure: The LION-HEART Multicentre Randomised Trial Josep Comín‐Colet, Nicolás Manito, Javier Segovia, European Journal of Heart Failure	2018	183
Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors María G. Crespo‐Leiro, Luis Alonso‐Pulpón, José A. Vázquez de Prada, American Journal of Transplantation	2008	151
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Circulation	2022	142
Primary graft failure after heart transplantation: Characteristics in a contemporary cohort and performance of the RADIAL risk score María Dolores García‐Cosío Carmena, Manuel Gómez‐Bueno, Luís Almenar, The Journal of Heart and Lung Transplantation Heart FailureTransplantationCardiovascular DiseaseRadial Risk ScorePrimary Graft Failure	2013	112
Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients H. Lehmkuhl, José M. Arizón, Mario Viganò, Transplantation	2009	95
Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency Andreas Zuckermann, Anne Keogh, María G. Crespo‐Leiro, American Journal of Transplantation UrologyTransplantationKidney TransplantRenal InsufficiencyMedicine	2012	85
Spanish Heart Transplantation Registry. 25th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013) Francisco González‐Vílchez, Manuel Gómez‐Bueno, Luís Almenar, Revista Española de Cardiología (English Edition) Heart FailureTransplantationCardiovascular EpidemiologyCardiovascular DiseaseHealth Policy	2014	82
Heart transplantation using allografts from older donors: Multicenter study results Eulàlia Roig, Luís Almenar, María G. Crespo‐Leiro, The Journal of Heart and Lung Transplantation TransplantationCardiovascular DiseaseGraft SurvivalOlder DonorsMedicine	2014	66
Similar Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS, Myfortic) Compared With Mycophenolate Mofetil (MMF) in De Novo Heart Transplant Recipients: Results of a 12-Month, Single-blind, Randomized, Parallel-group, Multicenter Study Jon Kobashigawa, Dale G. Renlund, Gino Gerosa, The Journal of Heart and Lung Transplantation Enteric-coated Mycophenolate SodiumTransplantationMycophenolate MofetilCardiovascular DiseaseMedicine	2006	66

Page 1